Michaela Ådén

Associate
  • Stockholm
  • Languages:
    Swedish, English

Education

  • Uppsala University, LLM, 2021
  • Uppsala University, Bachelor in Business Administration, 2020

Experience

  • Research Trainee, Gernandt & Danielsson, 2018–2020

Mandates

Mandate March 12, 2024

Vinge has advised Vimian Group in connection with its rights issue

Vinge has advised Vimian Group AB (publ) in connection with a partly guaranteed rights issue which w…

Mandate March 08, 2024

Vinge has advised Annehem Fastigheter AB (publ) in connection with its rights issue

Vinge has advised Annehem Fastigheter AB (publ) in connection with its rights issue of Class A and B…

Mandate December 19, 2023

Vinge has advised Annehem Fastigheter on the acquisition of a property

Vinge has advised Annehem Fastigheter AB (publ) in connection with the acquisition of the property T…

Mandate March 29, 2023

Vinge has adviced VNV Global in connection with a rights issue

Vinge has adviced VNV Global in connection with its fully secured rights issue of approximately SEK…

Mandate December 16, 2022

Vinge advises Acrinova AB (publ) in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Acrinova AB (publ) (“Acrinova” or the “Company”) in connection with the Company’s…

Mandate June 23, 2022

Vinge advises Goldman Sachs, J.P. Morgan, Nordea, Morgan Stanley and DNB Markets in connection with Millicom’s rights issue

Vinge advises Goldman Sachs International, J.P. Morgan Securities plc, Nordea Bank Abp, filial i Sve…

Mandate May 02, 2022

Vinge advises MGM on its public offer for LeoVegas

MGM Casino Next Lion, LLC has announced a recommended public offer to the shareholders of LeoVegas A…

Mandate January 18, 2022

Vinge advises Axcel VI and Currentum in connection with the acquisition of the Ipart Group

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of the Ipart Group…

Mandate November 11, 2021

Vinge advises Coloplast on the acquisition of Atos Medical

Vinge advises Danish healthcare company Coloplast on its acquisition of Atos Medical, the global mar…